213 related articles for article (PubMed ID: 36768816)
1. DDC-Promoter-Driven Chemogenetic Activation of SNpc Dopaminergic Neurons Alleviates Parkinsonian Motor Symptoms.
Seo DC; Ju YH; Seo JJ; Oh SJ; Lee CJ; Lee SE; Nam MH
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768816
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson's Disease.
Heo JY; Nam MH; Yoon HH; Kim J; Hwang YJ; Won W; Woo DH; Lee JA; Park HJ; Jo S; Lee MJ; Kim S; Shim JE; Jang DP; Kim KI; Huh SH; Jeong JY; Kowall NW; Lee J; Im H; Park JH; Jang BK; Park KD; Lee HJ; Shin H; Cho IJ; Hwang EM; Kim Y; Kim HY; Oh SJ; Lee SE; Paek SH; Yoon JH; Jin BK; Kweon GR; Shim I; Hwang O; Ryu H; Jeon SR; Lee CJ
Curr Biol; 2020 Jan; 30(2):276-291.e9. PubMed ID: 31928877
[TBL] [Abstract][Full Text] [Related]
3. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
[TBL] [Abstract][Full Text] [Related]
5. The hTH-GFP reporter rat model for the study of Parkinson's disease.
Iacovitti L; Wei X; Cai J; Kostuk EW; Lin R; Gorodinsky A; Roman P; Kusek G; Das SS; Dufour A; Martinez TN; Dave KD
PLoS One; 2014; 9(12):e113151. PubMed ID: 25462571
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
7. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Rai SN; Yadav SK; Singh D; Singh SP
J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
[TBL] [Abstract][Full Text] [Related]
9. Anesthetic Effects on the Progression of Parkinson Disease in the Rat DJ-1 Model.
Xu DA; DeYoung TP; Kondoleon NP; Eckenhoff RG; Eckenhoff MF
Anesth Analg; 2021 Nov; 133(5):1140-1151. PubMed ID: 34673725
[TBL] [Abstract][Full Text] [Related]
10. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.
Zhang Y; Meng X; Jiao Z; Liu Y; Zhang X; Qu S
ACS Chem Neurosci; 2020 Feb; 11(3):406-417. PubMed ID: 31909584
[TBL] [Abstract][Full Text] [Related]
11. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.
Acosta SA; Tajiri N; de la Pena I; Bastawrous M; Sanberg PR; Kaneko Y; Borlongan CV
J Cell Physiol; 2015 May; 230(5):1024-32. PubMed ID: 25251017
[TBL] [Abstract][Full Text] [Related]
13. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
Wang X; Yang HA; Wang XN; Du YF
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
[TBL] [Abstract][Full Text] [Related]
14. Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson's Model.
Lai JI; Porcu A; Romoli B; Keisler M; Manfredsson FP; Powell SB; Dulcis D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835612
[TBL] [Abstract][Full Text] [Related]
15. Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice.
Verma A; Ray A; Bapat D; Diwakar L; Kommaddi RP; Schneider BL; Hirsch EC; Ravindranath V
Mov Disord; 2020 Oct; 35(10):1843-1853. PubMed ID: 32618039
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.
Rangasamy SB; Dasarathi S; Pahan P; Jana M; Pahan K
J Neuroimmune Pharmacol; 2019 Jun; 14(2):173-187. PubMed ID: 30187283
[TBL] [Abstract][Full Text] [Related]
17. Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates.
Swanson C; Emborg M
Neurol Res; 2014 Jul; 36(7):634-46. PubMed ID: 24620964
[TBL] [Abstract][Full Text] [Related]
18. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
[TBL] [Abstract][Full Text] [Related]
19. Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.
Toti L; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G1013-23. PubMed ID: 25277799
[TBL] [Abstract][Full Text] [Related]
20. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
